Increased influenza-specific antibody avidity in HIV-infected women compared with HIV-infected men on antiretroviral therapy Zhenwu Background: It is recommended that HIV-infected individuals receive annual influenza vaccination due to their high susceptibility to influenza infection, especially among women. However, there have been few studies investigating sex-related responses to influenza vaccine in antiretroviral therapy (ART)-treated HIV-infected individuals.
Method: In this study, 26 aviremic ART-treated HIV-infected individuals and 16 healthy controls were enrolled in the current study. Blood was collected prior to vaccination (D0), on days 7-10 (D7) and on days 14-21 (D14) following administration of the 2013-2014 seasonal influenza vaccine. A series of analyses evaluated the serological and cellular responses following influenza vaccination.
Results: Female HIV-infected individuals had increased influenza-specific antibody avidity relative to male HIV-infected individuals, but similar plasma levels of influenza-specific binding antibodies and neutralizing antibodies. Increased cycling B cells and follicular helper CD4 þ T (Tfh) cells were observed in female HIV-infected individuals pre and postvaccination compared with male HIV-infected individuals, and cycling Tfh cells were directly correlated with influenza-specific antibody avidity. Moreover, plasma testosterone levels were inversely correlated with antibody avidity index. The magnitude of microbial translocation [plasma lipopolysaccharide (LPS)] level was directly correlated with influenza-specific antibody avidity. Circulating 16S rDNA microbiome showed that enrichment of specific species within Proteobacteria was associated with influenzaspecific antibody avidity. These results, including differences based on sex and correlations, were only observed in HIV-infected individuals but not in the healthy controls.
Introduction
HIV-1 infection is associated with an elevated incidence of influenza infection especially in women [1] . Seasonal influenza vaccination is highly recommended for all HIVinfected individuals [2] due to its ability to prevent influenza infection and reduce influenza-related morbidity and mortality [3] . It is unclear, however, whether there is a difference in the immune response to the influenza vaccine between men and women in this patient population.
Sex differences in immune responses against infectious diseases and vaccines have been shown among various populations in previous studies [4] . In general, men are more susceptible and experience more severe infections caused by parasites, fungi, bacteria and viruses due to their weak immune responses to these pathogens than women [5] . Moreover, many studies in healthy populations have found that women develop more robust antibody responses to vaccination than men [6] [7] [8] . However, women also develop higher inflammatory responses to vaccination, which result in increased adverse biological reactions to vaccination compared with men [9] .
During the 2009 H1N1 pandemic, women showed a higher mortality rate after exposure to the pathogenic influenza A virus than men [10] . This paradoxical effect may be related to the development of immune-mediated diseases during influenza infection that occur more frequently in women [11] . The increased risk of autoimmune diseases in women further supports this hypothesis [12] .
The purpose of the current study was to evaluate the difference in antibody response for men versus women in both HIV-infected individuals and healthy controls and characterize and link T and B cellular responses to serologic antibody responses. Understanding the immune perturbations in HIV can help improve the immunogenicity of vaccine regimens and establish guidelines to improve immune responses in this vulnerable population.
Materials and methods
Study design/population Twenty-six HIV-infected individuals and 16 healthy controls were included in the current analysis. Inclusion criteria for the HIV-infected individuals included current use of combination ART for at least 2 years and a plasma HIV-1 RNA less than 50 copies/ml. All individuals had received the influenza vaccine in the previous year and were enrolled prior to receiving the 2013-2014 influenza vaccine. The day of vaccine administration was designated as D0. Blood was collected on D0 prior to vaccination and then on days 7-10 (D7) and days 14-21 (D14) postvaccination. The study was approved by the institutional review board of the Medical University of South Carolina (Pro00020606); all individuals provided written informed consent. 
Influenza virus strains and vaccination

Flow cytometry
Whole blood was collected in EDTA-containing tubes for immediate plasma isolation and cryopreservation at -808C without prior thawing until analysis. Peripheral blood mononuclear cells (PBMCs) were isolated from the same tubes of whole blood over a Ficoll-Paque, and used for annexin V assays. Except for the annexin V assays, all other assays, such as Ki-67, the percentage of B and Tfh cells, were done using fresh whole blood samples. For surface staining, antibodies were incubated with either whole blood or PBMCs at room temperature for 15 min. After surface-staining of the whole blood, red cells were lysed, and the cells were washed and analysed by flow cytometry.
For Ki-67 staining, the Foxp3 buffer sets (eBioscience, San Diego, California, USA) were used according to the manufacturer's protocol. The fluorochrome-labelled mAbs used in this study included antihuman CD3 (OKT3), antihuman CD4 (RPA-T4), antihuman CD8 (RPA-T8), antihuman CD27 (M-T271), antihuman CD45RA (HI100), antihuman CD38 (HIT2), antihuman IgD (IA6-2), antihuman CD19 (HIB19), antihuman CXCR5 (RF8B2), antihuman CXCR3 (G025H7), antihuman PD1 (MIH4), antihuman Ki-67 (Ki-67), annexin V (BD Pharmingen, San Diego, California, USA) and isotype control Abs (BD Pharmingen). Cells without annexin V staining were used as controls for the apoptosis gating strategy. All others were gated based on isotypes. Cells were collected in a Guava 8HT flow cytometer (Millipore, Billerica, Massachusetts, USA), and data were analysed by FlowJo software (Version 10.0.8, Flowjo LLC, Ashland, Oregon, USA).
ELISA for influenza-specific antibody Microtiter plates were coated with a 1 : 20 dilution of the 2013-2014 seasonal influenza vaccine. Diluted plasma was added to each well for 1 h at room temperature. After washing, biotin-labelled goat antihuman IgG, IgM or IgA (KPL, Gaithersburg, Maryland, USA) was added to the microtiter wells and cultured for 60 min. Horseradish peroxidase conjugated streptavidin (HRP-streptavidin) and 2,2'-Azino-di (3-ethylbenzthiazoline-6-sulfonate) (ABTS) substrate solution were used to detect binding. Absorbance was measured at 405 nm; antibody concentrations were calculated in duplicates using a standard curve (12.5-1000 pg/ml).
ELISA for hormone detection Plasma testosterone, progesterone and 17b-oestrogen levels were measured by human hormone ELISA kit (Abcam, Cambridge, UK) according to the manufacturer's protocol.
Microneutralization assay
This method is described in detail in our previous study [13] . Briefly, plasma samples were serially diluted and heat-inactivated. Plasma samples were mixed with tissue culture infective doses (TCID50) for the H1N1 virus. The cells were cultured, and the presence of viral protein was detected by ELISA. The endpoint titre was calculated by the reciprocal of the highest dilution of plasma with an OD value less than X, where X ¼ [(average of V wells) À (average of C wells)]/2 þ (average of C wells).
Antibody avidity index
The modified avidity index detection was performed by ELISA-based methods [14] . Briefly, plates were initially coated with a 1 : 20 dilution of the 2013-2014 seasonal influenza vaccine, and plasma samples were diluted to yield an optical density (OD) of 1.0 AE 0.2. One hundred microlitre of the diluted plasma was added to each well for 1 h with shaking at room temperature. After washing, 100 ml of 0.5-2.5 mol/l GuHCl was added for 15 min, and buffer without GuHCl was added to set as a control. Horseradish peroxidase conjugated-labelled goat antihuman IgG (KPL, Gaithersburg, Maryland, USA) was added to the microtiter wells and cultured for 60 min. ABTS substrate solution was used to detect binding, and absorbance was measured at 405 nm. The avidity index was defined as the ratio of the area with GuHCl to the area without GuHCl.
Plasma lipopolysaccharide
Plasma samples were pretreated by dilution to 10% with endotoxin-free water and subsequent heating to 858C for 15 min to inactivate inhibitory proteins. Plasma LPS levels were then measured by the endpoint chromogenic Limulus amebocyte lysate (LAL) assay kit (Lonza, Switzerland) according to the manufacturer's protocol. Background was subtracted, and LPS levels were calculated by the standard regression line.
Enzyme-linked immunospots for plasmablasts and memory B cells
The frequencies of influenza-specific IgG ASCs were measured by EliSpot assays as previously described [15] . Briefly, plates were coated with the commercial 2013-2014 seasonal influenza vaccine (5 mg/ml) and incubated overnight at 48C. Total B cells were isolated from freshly prepared PBMCs using a negative selection kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Freshly isolated B cells (purity >95%) were cultured at the concentration of 0.5 million cells/well for 18-24 h at 378C, and the plates were incubated with a biotinylated mouse antihuman IgG (Jackson ImmunoResearch, West Grove, Pennsylvania, USA) for 2 h. Finally, the plates were incubated with alkaline phosphatase conjugated streptavidin and developed with substrate. Spots were enumerated with an AID reader and software (San Diego, California, USA).
Quantitative real-time reverse transcription-PCR analysis of mRNA expression
The total RNA from B cells was extracted using the RNeasy Micro kit following the manufacturer's manual (Qiagen, Valencia, California, USA). Complementary DNA was synthesized using SuperScript III (Invitrogen, Carlsbad, California, USA) as per the manufacturer's instructions. Gene expression analysis of MyD88 was performed by predeveloped real-time PCR (MyD88, Hs01573837_g1) (Invitrogen). Gene expression levels were transformed to relative normalized expression, which is shown as DDCq (Bio-Rad CFX Manager 3.1:, Hercules, California, USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as an endogenous control.
Plasma microbial DNA extraction, sequencing and data process Microbial DNA was extracted from 400 ml plasma and water control using QIAamp UCP Pathogen Mini kit (Qiagen) according to the manufacturer's instructions. The 16S rRNA gene V4 variable region PCR primers 515/806 with barcode on the forward primer were used in a 30-cycle PCR (five cycles used on PCR products) using the HotStarTaq Plus Master Mix Kit (Qiagen) under the following conditions: 948C for 3 min, followed by 28 cycles of 948C for 30 s, 538C for 40 s and 728C for 1 min, after which a final elongation step at 728C for 5 min was performed. After checking by 2% agarose gel to determine the success of amplification and the relative intensity of bands, samples were purified using calibrated Ampure XP beads (Beckman Coulter, Brea, California, USA) and then used to prepare the DNA library by following the Illumina TruSeq DNA library preparation protocol. Sequencing was performed at MR DNA (www.mrdnalab.com, Shallowater, Texas, USA) on a MiSeq following the manufacturer's guidelines.
The Q25 sequence data derived from the sequencing process was processed using a proprietary analysis pipeline (MR DNA; Shallowater, Texas, USA). Sequences were depleted of barcodes and primers; then, short sequences less than 200 bp, sequences with ambiguous base calls and sequences with homopolymer runs exceeding 6 bp were removed. Next, sequences were denoised and operational taxonomic units (OTUs) were defined clustering at 3% divergence (97% similarity), followed by removal of singleton sequences and chimeras. Final OTUs were taxonomically classified using BLASTn against a curated database derived from National Center for Biotechnology Information (NCBI) and Ribosomal Database Project (RDPII, East Lansing, Michigan, USA) and compiled into each taxonomic level into both 'counts' and 'percentage' files. To remove potential bacterial 16S rDNA contamination from molecular biological reagents, we removed genera from experimental samples at the OTU-level if they were detected in the water controls. OTU tables and different levels of taxonomy tables derived from the sequencing process described above were imported to R statistical software version 3.3.1 (The R Foundation for Statistical Computing, Vienna, Austria) for statistical analysis. Simpson index of diversity, which measures the richness and evenness of a microbiome community, was calculated using the Vegan package (The R Foundation) to measure a diversity of each sample.
Statistical analysis
Conventional measurements of the central location and dispersion were performed to describe the data, and the differences in continuous measurements between the two groups were compared by the Wilcoxon matched-pairs signed rank test (paired) or Mann-Whitney's U test (unpaired). To explore associations between pairs of continuous variables, Spearman's correlation test was used. Comparison analysis was performed using SPSS software version 16.01 (SPSS Inc., Chicago, Illinois, USA). All tests were two-sided, and P value less than 0.05 was used to denote statistical significance.
Results
Study population
Twenty-six HIV-infected individuals (nine women, 17 men) and 16 healthy controls (11 women, five men) were included in the current study. The clinical characteristics of the two groups are summarized in Table 1 .
Increased influenza-specific antibody avidity and hemagglutination inhibition titres in women compared with men in antiretroviral-treated HIV infection Serologic influenza-specific IgA, IgG and IgM titres were evaluated by ELISA. Antigen-specific IgG, IgA and IgM increased following vaccination in both HIV-infected individuals and controls with no statistically significant differences based on sex (Fig. 1a) . However, there was a trend towards higher vaccine-induced fold-changes of antigen-specific IgG and IgM on day 14 after vaccination (D14) compared with day 0 prior to vaccination (D0) in HIV-infected women compared with men (P ¼ 0.215, P ¼ 0.625, respectively) (Fig. 1b) .
We then performed viral micro-neutralization assays to detect the plasma titres of neutralizing antibodies, which are considered protective in influenza viral infection [16] . Consistently, seasonal influenza vaccination significantly induced neutralizing antibodies (NAbs) compared with baseline levels against H1N1, B and H3N2 strains in both HIV-infected individuals (P < 0.0001, P ¼ 0.023, P < 0.0001, respectively) and healthy controls (P ¼ 0.003, P ¼ 0.0005, P ¼ 0.044, respectively), but there were no statistically significant differences between the sexes observed in either group (Fig. 1c, d ).
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HIV-infected individuals (N ¼ 26)
Healthy controls (N ¼ 16) generation of high-affinity antibodies [17] . Therefore, in addition to neutralizing antibodies, the avidity of an antigen-specific antibody is thought to be an important factor in infection and disease [18] . To define the avidity of vaccine-specific antibodies, the guanidine hydrochloride (GuHCl)-modified ELISA method was applied [14] . Four concentrations of GuHCl (0.5, 1.0, 1.8 and 2.5 mol/l) were tested. The avidity index value was determined by plotting OD values against the four serum dilution factors. Two lines were plotted, one representing samples treated with GuHCl (condition-1) and one representing samples without any treatment (condition-2). This avidity index was calculated by the ratio of condition-1 to condition-2. Notably, HIV-infected women had increased IgG avidity index compared with HIV-infected men (Fig. 1e) , a difference that was not observed in the healthy control group (Fig. 1e) . These results suggest that HIV-infected women develop higher IgG avidity than HIV-infected men after receiving multiple seasonal influenza vaccines.
The plasma testosterone level correlation with antibody avidity index A previous study showed that hormones are one of the most important mediators of sex differences in immune responses [4] . Thus, we investigated the relationship between hormone levels and avidity index. We measured testosterone, progesterone and 17b-oestrogen in all individuals at D0. As expected, men from both the HIV-infected and healthy control groups had higher levels of testosterone than women. Interestingly, however, there were no statistically significant differences in 17b-oestrogen and progesterone levels in men versus women for either group (Fig. 2a-c) . We then investigated the association between hormone levels and antibody avidity.
Testosterone was inversely correlated with avidity index both at D0 and D14 in the HIV-infected individuals (Fig. 2d, e) but not in the healthy controls (D0: r ¼ 0.14, P ¼ 0.60; D14: r ¼ 0.28, P ¼ 0.30). There were no significant correlations between progesterone or 17b-oestrogen with antibody avidity for either group (data not shown). without stimulation, cytokines or other agonists. B cells activated by antigen are capable of rapid proliferation and differentiation into short-lived plasmablasts [19] . Because the peak transient responses of plasmablasts to the influenza vaccine occur in a short time period [20] , 7 days after vaccination (D7) was chosen as the collection time point. To determine changes in IgGþ ASC frequency postvaccination, the baseline frequency of IgGþ ASCs on D0 was subtracted from D7. Consistent with the serologic antibody result, the ASCs were dramatically increased after vaccination in all individuals from both groups regardless of sex (Fig. 3a) .
Next, the frequency and cycling of memory B cells were assessed by flow cytometry. The frequency of memory B cells in PBMCs was similar in men and women for both HIV-infected individuals and healthy controls (Fig. 3b) . The expression of Ki-67, a marker of proliferation and cycling in memory B cells [21, 22] , was elevated in HIVinfected women compared with everyone else (HIVinfected men and healthy male and female controls) both pre and postvaccination (Fig. 3c) . These results suggest increased activation of B cells in HIV-infected women compared with HIV-infected men and healthy controls regardless of vaccination status.
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Follicular helper CD4
þ T (Tfh) cells are the specialized providers for B cells in the germinal centre that assist in the development of SHM in ASCs and antibody affinity maturation [23, 24] . Therefore, we analysed the frequency of Tfh cells in total CD4
þ T cells in men and women on D0 and D7 (Fig. 3d) . Similar to B cell frequencies, there was no sex-based difference in the frequencies of Tfh cells at baseline or postvaccination for either group. Next, we assessed Tfh cell cycling, which is important for SHM and selection of germinal centre B cells [23] . A higher percentage Ki-67 expression in Tfh cells was seen in HIVinfected women on D7 after vaccination when compared with baseline, but not in HIV-infected men and healthy females and male controls (Fig. 3e) . Although HIVinfected women had higher Ki-67þ Tfh cells than HIVinfected men at D7 (Fig. 3e) , there was no sex difference in the healthy controls, consistent with our observed B cell response.
To determine if heightened Ki-67 expression in Tfh cells was related to high avidity index in HIV, we investigated the relationship between Ki-67þ Tfh cells and the avidity of serologic antibodies with both at D0 and then for Ki-67þ Tfh cells at D7 and the avidity of serologic antibodies at D7. We observed a positive correlation in both analyses between the frequency of cycling Tfh cells and the antibody avidity (Fig. 3f, g ). These significant correlations were not observed among the healthy controls (data not shown).
Lipopolysaccharide and the plasma microbiome are related to the antibody avidity index in HIVinfected individuals but not in healthy controls Toll-like receptors (TLRs) play an important role in antibody production, as TLR signalling is necessary for dendritic cell maturation, B cell activation and germinal centre formation [25, 26] . Therefore, we investigated whether the difference in the baseline level of systemic TLR agonists (e.g. LPS) was associated with vaccine antibody responses. Interestingly, plasma LPS levels tended to be higher in HIV-infected women relative to HIVinfected men, although the difference did not reach statistical significance (Fig. 4a) . Moreover, plasma LPS levels at baseline were positively correlated with both D0 and D14 antibody avidity after vaccination in HIV-infected individuals (Fig. 4b, c) , but neither of these relationships were significant among the healthy controls (data not shown).
To investigate TLR signalling pathway response to persistent LPS stimulation in vivo, we purified B cells at baseline and assessed mRNA relative expression of the MyD88 gene, an adaptor protein required for TLR signalling. Consistently, MyD88 expression at D0 tended to be higher in the HIV-infected women relative to the HIV-infected men, although it did not achieve statistical significance (Fig. 4d) . Furthermore, there was a direct correlation between the MyD88 expression and the antibody avidity index at D0 of vaccination in HIVinfected individuals (Fig. 4e) , but not in healthy controls (data not shown). The results indicate that the TLRs/ MyD88 pathway in B cells may be involved in antibody affinity maturation in ART-treated HIV-infected patients.
Studies of the microbiome have shown that distinct microbial species have different effects on the host immune system [27] . As the quantity of baseline systemic microbial translocation was associated with the antibody avidity (Fig. 4b) , we wanted to know whether the diversity of the translocated microbial species would affect the avidity of antibody. Using bacterial 16 s rDNA extracted from plasma, we identified microbial products via bacterial taxonomy through microbiome analysis. To control for potential 16S rDNA contamination from the reagents [28] , we removed genera from experimental samples at the OTU level if they were detected in the water controls. To compare overall microbial community diversity, the Gini Simpson diversity index was applied. The diversity of microbiota composition did not differ on the basis pf sex either in the HIV-infected group (P ¼ 0.907) or in the healthy control (P ¼ 0.317) (Fig. 4f) .
Next, we assessed the composition of plasma microbial communities within women and men in both the HIVinfected individuals and healthy controls. The predominant phylum-level products were similar in both HIVinfected individuals and controls with no differences based on sex. In HIV-infected women, predominant plasma phylum-level microbial products in order of decreasing prevalence were from Proteobacteria [% mean AE standard deviation (SD), 53.9% AE 20.8%], Firmicutes (21.0% AE 22.8%) and Actinobacteria (7.3% AE 8.9%), and, in HIV-infected men, the predominant products were from Proteobacteria (62.7% AE 20.2%), Firmicutes (16.8% AE 12.1%) and Actinobacteria (10.1% AE 10.1%). There was a lower ratio of Firmicutes/Proteobacteria in HIV-infected men than HIV-infected women (0.27 versus 0.39, respectively). In female controls, the predominant products were from Proteobacteria (49.1% AE 22.9%), Firmicutes (20.0% AE 19.7%) and Actinobacteria (18.0% AE 21.1%). In male controls, the predominant phylum-level products were from Proteobacteria (31.7% AE 22.0%), Firmicutes (27.6% AE 16.4%) and Actinobacteria (19.3% AE 19.4%) (Fig. 4g) . In healthy controls, the ratios of Firmicutes/Proteobacteria in men compared with women were 0.87 versus 0.41, respectively. Therefore, healthy controls had a greater ratio of Firmicutes/ Proteobacteria in both sexes.
Next, we analysed whether any species shown as the taxa at the OTU level were correlated with the antibody avidity within the HIV-infected individuals. We found a significant inverse correlation between antibody avidity and particular species within the Proteobacteria and Actinobacteria phyla (Fig. 4h) . We also found positive correlations between antibody avidity and particular species within the Firmicutes and Proteobacteria phyla. At the genus level, increased relative abundances of Enterobacter and Klebsiella were associated with decreased antibody avidity, while increased relative abundances of Attoposipes, Comamonas and Stenotrophomonas were associated with increased antibody avidity in HIV-infected individuals (Fig. 4h ).
Discussion
HIV-infected patients are at an increased risk for influenza viral infections and are considered to be a high-priority group for influenza vaccination [29] . However, impaired antibody responses to vaccination in ART-naive HIVinfected individuals have been reported [30, 31] . Importantly, our previous data showed that seasonal influenza vaccine serologic responses are comparable to healthy controls once HIV-infected patients have been successfully treated with ART [13] . The aim of this current study was to determine whether there is a difference based on sex in the serologic and cellular responses induced by seasonal influenza vaccination in ART-treated virologically suppressed HIV-infected individuals. Such a difference in response to vaccination based on sex has been shown previously in the general population, in which women mount a more robust immune response than men [32] [33] [34] . We found that the antibody avidity exhibited sex-based differences in the HIV-infected individuals, in whom women had an increased avidity index compared with men; this sex-based difference was not observed in the healthy control group. In addition, cycling of Tfh cells and memory B cells was increased in HIV-infected women compared with HIV-infected men, a finding again not observed among the healthy controls. On the contrary, neither the HIV-infected group nor healthy controls exhibited any sex-based differences in the frequency of memory B cells or Tfh cells.
We questioned whether the difference in antibody avidity could be attributed to a difference in the number of previous seasonal influenza vaccinations received between the two sexes. For some infections, such as HIV, antigenspecific antibodies acquire affinity development by continuous antigen stimulation [35] . However, longitudinal tracking of vaccine-induced hemagglutinationspecific clones has shown no overall increase in SHM over time [36] . Therefore, repeated annual influenza immunization likely does not enhance the quality of influenzaspecific antibody [37] , making the hemagglutinationspecific avidity difference that we observed between male and female HIV-infected individuals unlikely to be attributable to a difference in the number of previous vaccinations. Nonetheless, there was no sex difference in the frequencies of previous seasonal influenza vaccinations in HIV-infected individuals (Table 1) .
We also observed a difference in Tfh cell cycling expression in HIV-infected men and women, which was not seen among the healthy controls, but there was no difference in the number of cells for either group. Tfh cells are specialized providers of B cell help and are essential for generating a protective and high-affinity humoral response to antigen stimulation [38, 39] . The selective survival and expansion of antigen-specific germinal centre B cell clones carrying somatic mutations account for the progressive increase in antibody affinity after vaccination [24] . Thus, the higher cycling expression in Tfh cells and memory B cells in HIV-infected women than men in our study indicates that Tfh cell activation may contribute to the antibody avidity difference observed between the sexes. Interestingly, testosterone was inversely correlated with antibody avidity index in our study for the HIV-infected group (a correlation not observed among the healthy controls), but there was no association with influenzaspecific NAb or binding antibodies. Our data are in line with other studies that testosterone provides an immunosuppressive function. Testosterone downregulates the expression of TLR4 on monocytes and macrophages, causing a diminished LPS-induced inflammatory cytokine response [40] , which ultimately leads to a decrease in T and B cell proliferation [41] .
In addition, plasma LPS levels at baseline were positively correlated with the antibody avidity in HIV-infected individuals, a correlation again not observed among the healthy controls. Our previous data showed that the plasma level of TLR4 ligand LPS was associated with inflammation and B cell activation in HIV disease [42] . Furthermore, high-affinity influenza-specific antibodies driven by TLRs have been found in systemic lupus erythematosus patients in response to vaccination [43] . As the receptor for LPS, TLR4 signalling in B cells has been reported to increase B cell migration and accumulation in germinal centre dark zones, perhaps helping germinal centre reactions [44] . Knockout of TLR4 or MyD88, one of the adaptor proteins required for signalling from TLR4, results in a reduced percentage of germinal centre B cells compared with wild-type B cells [45] , suggesting that the TLR4/ MyD88 signalling pathway may help B cell retention and development in the GC. Consistent with our observed positive correlation between LPS and antibody avidity among the HIV-infected group, we also identified a similar correlation in our study between LPS and the mRNA level of MyD88 gene expression in B cells in the HIV-infected group but not within the healthy controls. These results suggest that microbial translocation and/or TLR signalling may play a role in the increased antibody avidity in ART-treated virologically suppressed HIVinfected women. Moreover, our plasma microbiome analysis showed that a lower ratio of Firmicutes/ Proteobacteria in HIV-infected individuals relative to healthy controls regardless of sex, which is consistent with gut microbiome found in HIV patients [46] . In addition, a particular microbiome was associated with antibody avidity in HIV-infected individuals.
We found that increased relative abundance of Enterobacter cloacae and Klebsiella spp. was associated with decreased antibody avidity in HIV-infected individuals. Previously, studies showed that E. cloacae was invasive to epithelial cells [47] and induced lysis of the murine macrophage J774 cell line [48] . These findings suggest that E. cloacae may adhere to and penetrate epithelial cells, induce apoptosis and affect antigen phagocytosis and presentation. In general, B cell proliferation and germline mutation in the germinal centre are necessary for antibody affinity mutation [24] . Notably, Klebsiella pneumoniae, one of Klebsiella spp., has been shown to stimulate human B cells to mature into plaque forming cells without prior B cell proliferation [49] . In the future, we will identify the effects of these bacteria on host immunities, as this has a great therapeutic potential.
Previously, studies showed that women had increased antibody responses following influenza virus vaccination in the general population, including influenza hemagglutinin inhibition and neutralizing antibody titres against H1N1, H3N2 and influenza B antigens [34, 50] . However, we did not observe any sex differences in the cellular and serologic responses to the influenza vaccine within our healthy control group. This may be due to the small sample size in the control group, which limited our ability to detect sex differences. In addition, the frequencies of previous vaccination in healthy controls are not available in the current study, which could be responsible for some of the sex differences seen in our study between the healthy controls and HIVinfected subjects, as well as differences in our findings compared to previous studies [51] . However, our findings within the HIV-infected group are consistent with the immunological changes seen in chronic HIV infection and shed light on the unique aspects and sex-based differences in the immune response to influenza vaccine in this vulnerable population.
It is unclear, however, whether increased influenzaspecific antibody avidity in HIV-infected women represents increased degree of protection from influenza infection. As shown in the general population, it may represent a stronger vaccine responsiveness in HIVinfected women than HIV-infected men. However, women have shown an increased risk of severe influenzaassociated complications compared with men [52] , and increased titre and avidity of influenza-specific non-NAb after influenza virus infection were associated with clinical severity and poorer outcomes in the general population [18] . Furthermore, animals with high avidity anti-HA2 antibodies had increased H1N1 infection through promoting viral membrane fusion compared with animals with low avidity antibody responses [53] . In the current study, antibody avidity is independent of the titres of protective influenza-specific antibodies generated in response to vaccination in HIV-infected individuals, suggesting that antibody avidity may not be associated with protections against influenza infection. Future studies on the clinical significance of increased avidity antibody responses in HIV-infected women may provide information on vaccination strategies in ART-treated HIV-infected patients.
